STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more

MAP Verified Summary — reported by STAT News

European regulators are taking what advocates say is unexpectedly “rapid action” to ensure trial results are made public as required by law.

This story was scored across MAP’s five-signal verification framework — Context, Presentation, References, Visibility, and Comparison — as part of Media Alert Press’s independent media credibility index. Read the full original story at STAT News →